# RNTX (Rein Therapeutics, Inc.) - SEC EDGAR Financial Statements

> Rein Therapeutics, Inc. reported $0 in revenue and a net loss of $49.72M for the trailing twelve months ended September 30, 2026.

- Canonical: https://convexityos.com/fundamentals/RNTX
- Markdown: https://convexityos.com/fundamentals/RNTX.md
- SEC CIK: 0001420565
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:52 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001420565&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $0 | Sep 30, 2026 |
| Operating Income | TTM | -$50.96M | Operating profit |
| Net Income | TTM | -$49.72M | GAAP bottom line |
| Diluted EPS | TTM | -$0.56 | Split-adjusted |
| Free Cash Flow | TTM | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $35.49M | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Research & Development | $11.03M | $14.25M | $3.99M | $17.97M | $17.01M | $11.17M | $17.66M | $18.45M | $14.24M | $10.28M |
| Total Operating Expenses | $50.63M | $65.11M | $16.28M | $27.65M | $26.61M | $20.50M | $29.96M | $31.90M | $23.01M | $18.17M |
| **Operating Income** | -$50.63M | -$65.11M | -$16.28M | -$27.65M | -$26.61M | -$20.50M | -$29.96M | -$31.90M | -$23.01M | -$18.17M |
| **EBITDA** | -$50.63M | -$65.05M | -$16.16M | -$27.48M | -$26.48M | -$20.33M | -$29.80M | -$31.68M | -$22.88M | -$17.94M |
| Income Tax Expense | -$712K | -$1.54M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$49.87M | -$62.88M | -$15.73M | -$27.33M | -$26.16M | -$27.33M | -$29.37M | -$31.55M | -$22.60M | -$18.12M |
| Basic EPS | -$1.96 | -$3.51 | -$3.42 | -$6.02 | -$117.80 | -$12.20 | -$24.00 | -$42.80 | -$60.80 | -$847.00 |
| **Diluted EPS** | -$1.96 | -$3.51 | -$3.42 | -$6.02 | -$117.80 | -$12.20 | -$24.00 | -$42.80 | -$60.80 | -$847.00 |
| Basic Shares Outstanding | 25.4M | 17.9M | 4.6M | 4.5M | 222.0K | 1.7M | 1.2M | 736.9K | 372.2K | 21.5K |
| Diluted Shares Outstanding | 25.4M | 17.9M | 4.6M | 4.5M | 222.0K | 1.7M | 1.2M | 736.9K | 372.2K | 21.5K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Research & Development | $4.38M | $3.64M | $3.07M | $2.00M | $1.68M | $4.29M | $3.05M | $3.32M |
| Total Operating Expenses | $7.00M | $6.08M | $5.23M | $32.66M | $5.49M | $6.87M | $5.61M | $42.80M |
| **Operating Income** | -$7.00M | -$6.08M | -$5.23M | -$32.66M | -$5.49M | -$6.87M | -$5.61M | -$42.80M |
| **EBITDA** | -- | -- | -- | -$32.66M | -$5.49M | -$6.87M | -$5.61M | -$42.80M |
| **Net Income** | -$5.54M | -$6.38M | -$5.84M | -$31.97M | -$5.58M | -$6.82M | -$5.50M | -$40.98M |
| Basic EPS | -$0.06 | -$0.10 | -$0.19 | -- | -$0.21 | -$0.28 | -$0.25 | -- |
| **Diluted EPS** | -$0.06 | -$0.10 | -$0.19 | -- | -$0.21 | -$0.28 | -$0.25 | -- |
| Basic Shares Outstanding | 88.3M | 67.1M | 30.4M | -- | 26.4M | 24.2M | 21.9M | -- |
| Diluted Shares Outstanding | 88.3M | 67.1M | 30.4M | -- | 26.4M | 24.2M | 21.9M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $3.21M | $12.87M | $17.34M | $5.19M | $3.60M | $7.05M | $5.31M | $10.63M | $11.86M | $20.71M |
| Short-Term Investments | $0 | -- | -- | $16.05M | $42.33M | $6.76M | $12.97M | $10.06M | $38.89M | $0 |
| **Cash & Short-Term Investments** | $3.21M | $12.87M | $17.34M | $21.24M | $45.93M | $13.80M | $18.28M | $20.70M | $50.75M | $20.71M |
| Other Current Assets | $881K | $676K | $675K | $606K | -- | -- | -- | -- | -- | -- |
| **Total Current Assets** | $4.33M | $13.66M | $18.27M | $21.87M | $48.18M | $16.33M | $19.55M | $21.77M | $51.84M | $21.07M |
| Property, Plant & Equipment, Net | $0 | $1.0K | $19K | $70K | $128K | $15K | $295K | $7.29M | $154K | $107K |
| Goodwill | $6.33M | $6.33M | $6.33M | -- | -- | -- | -- | -- | -- | -- |
| Intangible Assets | $13.50M | $42.20M | $79.20M | -- | -- | -- | -- | -- | -- | -- |
| Long-Term Investments | $0 | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Other Non-Current Assets | $2.0K | $2.0K | $2.19M | $24K | $24K | -- | -- | $679K | $694K | $778K |
| **Total Non-Current Assets** | $19.83M | $48.53M | $87.74M | $134K | $304K | $15K | $6.92M | $8.54M | $848K | $948K |
| **Total Assets** | $24.16M | $62.19M | $106.0M | $22.01M | $48.48M | $16.34M | $26.47M | $30.31M | $52.69M | $22.02M |
| Accounts Payable | $3.98M | $911K | $1.19M | $1.72M | $1.21M | $1.60M | $1.45M | $1.73M | $1.60M | $1.97M |
| **Total Current Liabilities** | $6.18M | $5.75M | $4.38M | $3.38M | $4.51M | $3.96M | $5.84M | $5.37M | $4.89M | $4.07M |
| Other Non-Current Liabilities | $0 | $277K | -- | -- | -- | -- | -- | -- | -- | -- |
| **Total Non-Current Liabilities** | $1.06M | $2.05M | $3.33M | $0 | $69K | $219K | $4.59M | $5.34M | $0 | $11K |
| **Total Liabilities** | $7.24M | $7.80M | $7.71M | $3.38M | $4.58M | $4.18M | $10.43M | $10.71M | $4.89M | $4.08M |
| **Total Debt (incl. Leases)** | -- | -- | $48K | $48K | $162K | -- | $5.03M | $5.40M | -- | -- |
| Common Stock | $113K | $108K | $91K | $91K | $91K | $44K | $28K | $15K | $15K | $0 |
| Retained Earnings | -$401.3M | -$351.4M | -$288.5M | -$272.8M | -$245.5M | -$219.3M | -$198.1M | -$168.5M | -$136.9M | -$114.3M |
| Accumulated Other Comp. Income | -$62K | -$18K | -$63K | -$48K | -$13K | -$2.0K | $7.0K | -$5.0K | -$33K | -- |
| **Total Stockholders' Equity** | $16.92M | $54.39M | $98.30M | $18.62M | $43.90M | $12.16M | $16.05M | $19.60M | $47.80M | -$111.8M |
| Total Equity | $16.92M | $54.39M | $98.30M | $18.62M | $43.90M | $12.16M | $16.05M | $19.60M | $47.80M | -$111.8M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $943K | $8.54M | $4.45M | $3.21M | $4.05M | $5.72M | $7.43M | $12.87M |
| Short-Term Investments | $34.55M | $32.10M | -- | $0 | -- | -- | -- | -- |
| **Cash & Short-Term Investments** | $36.49M | $43.63M | $4.45M | $3.21M | $4.05M | $5.72M | $7.43M | $12.87M |
| Other Current Assets | $1.23M | $727K | $918K | $881K | $997K | $692K | $864K | $676K |
| **Total Current Assets** | $36.78M | $41.45M | $5.45M | $4.33M | $5.17M | $6.60M | $8.33M | $13.66M |
| Property, Plant & Equipment, Net | -- | -- | -- | $0 | $0 | $1.0K | $1.0K | $1.0K |
| Goodwill | $6.33M | $6.33M | $6.33M | $6.33M | $6.33M | $6.33M | $6.33M | $6.33M |
| Intangible Assets | $13.50M | $13.50M | $13.50M | $13.50M | $42.20M | $42.20M | $42.20M | $42.20M |
| Long-Term Investments | $994K | $2.98M | -- | $0 | -- | -- | -- | -- |
| Other Non-Current Assets | $1.82M | $1.71M | $1.00M | $2.0K | $2.0K | $2.35M | $766K | $2.0K |
| **Total Non-Current Assets** | $22.64M | $24.52M | $20.84M | $19.83M | $48.53M | $50.88M | $49.30M | $48.53M |
| **Total Assets** | $59.43M | $65.97M | $26.29M | $24.16M | $53.71M | $57.48M | $57.63M | $62.19M |
| Accounts Payable | $3.20M | $4.47M | $6.26M | $3.98M | $4.12M | $6.03M | $1.15M | $911K |
| **Total Current Liabilities** | $5.60M | $9.71M | $13.64M | $6.18M | $5.74M | $7.69M | $5.98M | $5.75M |
| Other Non-Current Liabilities | -- | -- | -- | $0 | $0 | $0 | $0 | $277K |
| **Total Non-Current Liabilities** | $1.06M | $1.06M | $1.06M | $1.06M | $1.77M | $1.77M | $1.77M | $2.05M |
| **Total Liabilities** | $6.66M | $10.77M | $14.70M | $7.24M | $7.52M | $9.47M | $7.75M | $7.80M |
| Common Stock | $172K | $172K | $114K | $113K | $111K | $109K | $108K | $108K |
| Retained Earnings | -$419.0M | -$413.5M | -$407.1M | -$401.3M | -$369.3M | -$363.7M | -$356.9M | -$351.4M |
| Accumulated Other Comp. Income | -$115K | -$69K | -$62K | -$62K | -$44K | -$44K | -$32K | -$18K |
| **Total Stockholders' Equity** | $52.77M | $55.20M | $11.59M | $16.92M | $46.19M | $48.01M | $49.88M | $54.39M |
| Total Equity | $52.77M | $55.20M | $11.59M | $16.92M | $46.19M | $48.01M | $49.88M | $54.39M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$49.87M | -$62.88M | -$15.73M | -$27.33M | -$26.16M | -$21.16M | -$29.37M | -$31.55M | -$22.60M | -$18.12M |
| Depreciation & Amortization | $1.0K | $63K | $119K | $169K | $121K | $163K | $155K | $218K | $129K | $232K |
| Stock-Based Compensation | $2.22M | $1.12M | $1.19M | $2.08M | $2.26M | $1.89M | $2.12M | $3.28M | $1.75M | $688K |
| Change in Payables | $3.06M | -$279K | -$4.98M | $510K | -$386K | $116K | -$277K | $130K | -$241K | $1.22M |
| **Operating Cash Flow** | -$19.36M | -$22.29M | -$19.81M | -$24.86M | -$23.75M | -$20.48M | -$26.47M | -$27.93M | -$20.53M | -$15.01M |
| Capital Expenditure | -- | -- | -- | -- | -$157K | -$5.0K | -$151K | -$4.42M | -$142K | -- |
| **Free Cash Flow** | -- | -- | -- | -- | -$23.91M | -$20.48M | -$26.62M | -$32.35M | -$20.67M | -- |
| Acquisitions, Net | -- | $0 | -$96K | $0 | -- | -- | -- | -- | -- | -- |
| Purchases of Investments | -- | -- | -- | -$21.85M | -$73.58M | -$10.03M | -$27.24M | -$31.19M | -$71.06M | -$12.63M |
| **Investing Cash Flow** | -- | $0 | $16.20M | $26.46M | -$35.92M | $6.41M | -$2.81M | $24.69M | -$38.91M | -$25K |
| Common Stock Issued | $1.82M | $10.64M | $0 | -- | -- | $16.88M | -- | -- | -- | -- |
| **Financing Cash Flow** | $9.76M | $17.82M | $15.79M | -- | $55.66M | $15.80M | $23.96M | $2.52M | $50.59M | $31.99M |
| **Net Change in Cash** | -$9.65M | -$4.47M | $12.12M | $1.59M | -$4.01M | $1.74M | -$5.32M | -$723K | -$8.85M | $16.95M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$5.54M | -$6.38M | -$5.84M | -$31.97M | -$5.58M | -$6.82M | -$5.50M | -$40.98M |
| Depreciation & Amortization | -- | -- | -- | $0 | $0 | $1.0K | $0 | $0 |
| Stock-Based Compensation | $534K | $164K | $156K | $257K | $1.45M | $256K | $264K | $133K |
| Change in Payables | -$1.27M | -$1.89M | $2.29M | -$147K | -$1.91M | $4.88M | $238K | -$168K |
| **Operating Cash Flow** | -$7.27M | -$8.64M | -$3.42M | -$3.22M | -$3.55M | -$6.42M | -$6.17M | -$4.81M |
| **Investing Cash Flow** | -- | -- | -- | -- | -- | -- | -- | $0 |
| Common Stock Issued | $0 | $53.19M | $354K | -$448K | $1.90M | -$370K | $737K | $0 |
| **Financing Cash Flow** | $0 | $47.81M | $4.65M | $2.40M | $1.90M | $4.71M | $738K | $1.0K |
| **Net Change in Cash** | -$7.60M | $4.10M | $1.23M | -$833K | -$1.67M | -$1.71M | -$5.44M | -$4.81M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -294.8% | -115.6% | -16.0% | -146.7% | -59.6% | -224.7% | -183.0% | -161.0% | -47.3% | -- |
| Return on Assets (ROA) | -206.4% | -101.1% | -14.8% | -124.2% | -54.0% | -167.2% | -110.9% | -104.1% | -42.9% | -82.3% |
| Current Ratio | 0.70x | 2.38x | 4.17x | 6.46x | 10.69x | 4.12x | 3.35x | 4.05x | 10.60x | 5.18x |
| Quick Ratio | 0.52x | 2.24x | 3.95x | 6.28x | 10.19x | 3.49x | 3.13x | 3.85x | 10.38x | 5.09x |
| Debt to Equity | -- | -- | 0.00x | 0.00x | 0.00x | -- | 0.31x | 0.28x | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -94.2% | -90.1% | -433.2% | -294.8% | -127.5% | -123.2% | -122.8% | -115.6% |
| Return on Assets (ROA) | -83.7% | -75.4% | -191.0% | -206.4% | -109.6% | -102.9% | -106.3% | -101.1% |
| Current Ratio | 6.57x | 4.27x | 0.40x | 0.70x | 0.90x | 0.86x | 1.39x | 2.38x |
| Quick Ratio | 6.52x | 4.49x | 0.33x | 0.52x | 0.70x | 0.74x | 1.24x | 2.24x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
